(Date:12/1/2008).... 1 Vapotherm, the glob...nounced today that President and CEO, Robert Store...are conference on Wednesday, December 3rd at 1:30 ... The conference brings together public and privat... to present and discuss trends, advances, challeng...
(Date:12/1/2008)...Newswire-USNewswire/ -- The following is a state...Trust for America,s Health (TFAH) in response to t...eport on the Food Protection Plan: , , "The...e staff at the FDA should be commended for moving ...safety, but they can only achieve limited success ...
(Date:12/1/2008)... Welvista is pleased to announce i...S., one of the world,s leading,pharmaceutical com...he,uninsured through Welvista,s no-cost prescript...sanofi-aventis drugs from the company,s Patient As...ugs on its formulary for the,uninsured. Including...
(Date:12/1/2008)...ec. 1 Pressure BioScienc...) today announced a comprehensive restructuring pr...ralize core operations, and refocus the Company,s ...any,s products have found significant market accep..., -- a reduction in personnel of eight full-tim...
Breaking Medicine News(10 mins):Health News:TFAH Statement: FDA Food Protection Plan is Insufficient 2Health News:Welvista Announces Partnering with sanofi-aventis U.S. to Provide Medication at No Cost to the Uninsured 2Health News:Pressure BioSciences, Inc. Announces Restructuring, Significant Cost Reduction Initiatives, and Sharpened Focus 2Health News:Pressure BioSciences, Inc. Announces Restructuring, Significant Cost Reduction Initiatives, and Sharpened Focus 3Health News:Pressure BioSciences, Inc. Announces Restructuring, Significant Cost Reduction Initiatives, and Sharpened Focus 4Health News:Pressure BioSciences, Inc. Announces Restructuring, Significant Cost Reduction Initiatives, and Sharpened Focus 5Health News:Pressure BioSciences, Inc. Announces Restructuring, Significant Cost Reduction Initiatives, and Sharpened Focus 6Health News:Pressure BioSciences, Inc. Announces Restructuring, Significant Cost Reduction Initiatives, and Sharpened Focus 7...ily life and more so of newborn babies who in thei...or over 18 hours. However, it is different with so...eported in Nature that newborn bottlenose dolphins...the first month. Their moms manage with only a win...
...een a major killer in the last two years in July 2...nfected a further 8,000. A collaborative group of ...d have spent the past year screening more than 8,0...t SARS and now have identified 15 existing drugs ...
...) issued a public health advisory to inform patien...d marketing of Tysabri (nataluzimab) the drug mean...MS) which was approved by the FDA in 2004. FDA s...uspend marketing of the drug as well as the use of...
...erm a single drug may be used to treat both the ph...a psychotic disorder characterized by successive f...anic-depressive illness that affects 3 to 4 5 of t...chronic condition and most of the sufferers have m...
Other Medicine News:
DSL's unique DHEA-S-7kits feature a highly specific antiserum targeted against the C-7 position of the DHEA-S molecule, with no cross-reactivity with DHEA. DSL's DHEA-S Saliva RIA has been optimized
Inquire
Rapid latex slide agglutination assay for the qualitative and semi-quantitative determination of Rheumatoid Factors in human serum.
Equipped with the SYNCHRON CX4 PRO, which includes many of today's most advanced and automated technologies, your laboratory can improve its specialty testing process dramatically. The SYNCHRON CX4 P
Medicine Products:(Date:11/28/2008)...ll/ -- Eli Lilly and Company,(NYSE: LLY ) has w...DA) from,the U.S. Food and Drug Administration (F...gement of chronic pain. Lilly plans to resubmit th...ata from a recently completed positive study,in c...he decision does not affect duloxetine,s FDA-appro...
(Date:11/26/2008)... and intelligent clinical applications take workfl... , CHICAGO, Ill., Nov. 26 /PRNewswire-FirstC...ealthcare ) highlights the ACUSON S2000(TM) Autom... first multi-use, automated volume breast ultrasou...ual Meeting of the Radiological Society of North A...
(Date:11/25/2008)...wswire/ -- Kleinert Kutz and University of Louisv...transplant on Messina, New York resident, Jan "Eri...Care Center on Monday, November 24. The innovativ...ortly after 9 p.m. in a record nine hours. , ,...20081125/DC48555-a ) , (Photo: http://www.new...
(Date:11/25/2008)...ewswire-FirstCall/ -- Poniard,Pharmaceuticals, In...focused on,innovative oncology therapies, announc...rnatives for its preclinical research programs in ... on the clinical development of picoplatin,its l...commercialization of,picoplatin in the treatment ...
Breaking Medicine Technology:Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 4Siemens Introduces New Standard of Care for Breast Ultrasound 2Siemens Introduces New Standard of Care for Breast Ultrasound 3Siemens Introduces New Standard of Care for Breast Ultrasound 4Siemens Introduces New Standard of Care for Breast Ultrasound 5Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 2Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 3Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 2Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 3Kidney function discovery sheds light on genetic complexity of disease 6056 1Kidney function discovery sheds light on genetic complexity of disease 6056 2MySignatureBook Certified Compliant With SAFE BioPharma Digital Standard 28TM 29 9382 1MySignatureBook Certified Compliant With SAFE BioPharma Digital Standard 28TM 29 9382 2MySignatureBook Certified Compliant With SAFE BioPharma Digital Standard 28TM 29 9382 3The SCOOTER Store Gives Power Wheelchair to Good Samaritan Critically Injured Trying to Save Others 30689 1The SCOOTER Store Gives Power Wheelchair to Good Samaritan Critically Injured Trying to Save Others 30689 2The SCOOTER Store Gives Power Wheelchair to Good Samaritan Critically Injured Trying to Save Others 30689 3Resverlogix Board of Directors Update 9378 1Resverlogix Board of Directors Update 9378 2...2007 /PRNewswire-FirstCall/ --,Alpharma Inc. , a l...ough its Pharmaceuticals Division, this week prese...f its investigational,abuse-deterrent, extended-re... of the American Pain Society in Washington, D.C.,...of this,extended-release morphine sulfate plus seq...
...t="_blank" href=,"http://www.omxgroup.com/">www.om... DMYDY) , , STOCKHOLM, Sweden, May 3, 2007 &ndas... at the Sweden-Seattle Diabetes Conference,this pa...cipal,Investigator in Diamyd’s previously re...s, presented potentially scientifically,ground-bre...
Other Medicine Technology:Alpharma Presents Positive Pharmacokinetic Study Results of Its,Investigational Abuse-Deterrent, Extended-Release Opioid 2Alpharma Presents Positive Pharmacokinetic Study Results of Its,Investigational Abuse-Deterrent, Extended-Release Opioid 3Alpharma Presents Positive Pharmacokinetic Study Results of Its,Investigational Abuse-Deterrent, Extended-Release Opioid 4Revolutionary Immunologic Data Explains Function of Diamyd Diabetes,Vaccine 2Revolutionary Immunologic Data Explains Function of Diamyd Diabetes,Vaccine 3Revolutionary Immunologic Data Explains Function of Diamyd Diabetes,Vaccine 4Revolutionary Immunologic Data Explains Function of Diamyd Diabetes,Vaccine 5